PROVERA

LOE Approaching

medroxyprogesterone acetate

NDAORALTABLET
Approved
Jun 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
10

Clinical Trials (5)

NCT04682353Phase 1Completed

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

Started Dec 2020
60 enrolled
Contraception
NCT03255941Phase 1Completed

Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers

Started Mar 2018
460 enrolled
Contraception
NCT02817464Phase 1Completed

Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Started Oct 2016
12 enrolled
PregnancyContraception
NCT02509767Phase 4Completed

Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood

Started Aug 2015
401 enrolled
Contraception
NCT00770887N/ACompleted

Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate

Started May 2010
50 enrolled
Fertility